Need Help?

Plasma whole genome sequencing from patients with stage IV colorectal cancer and microsatellite instability

This dataset contains plasma WGS data from patients with stage IV colorectal cancer (CRC, n = 16) and healthy individuals (n = 21) used in the Pointy manuscript. Patients with CRC provided written consent and samples were collected as performed as described previously ( number NCT01876511; Georgiadis et al., 2019, Le et al., 2017). Plasma samples from 21 healthy control individuals were procured through BioIVT. Cell-free DNA (cfDNA) was extracted from plasma using the QIAamp Circulating Nucleic Acid Kit. Libraries were prepared with 5 to 250 ng of cfDNA using the NEBNext DNA Library Prep Kit. Libraries were sequenced on HiSeq2000/2500.

Request Access

Data Access Agreement (DAA) for plasma whole genome sequencing from patients with stage IV colorectal cancer. The DAA must be signed by the User Institution and MSKCC. User Institutions must outline the proposed project (Appendix II) and agree to the publication policy (Appendix III) in the DAA. Please see DAA terms.

DATA ACCESS AGREEMENT These terms and conditions govern access to the managed access datasets (details of which are set out in Appendix I) to which the User Institution has requested access. The User Institution agrees to be bound by these terms and conditions. Definitions Authorised Personnel: The individuals at the User Institution to whom Memorial Sloan Kettering Cancer Center grants access to the Data. This includes the User, the individuals listed in Appendix II and any other individuals for whom the User Institution subsequently requests access to the Data. Details of the initial Authorised Personnel are set out in Appendix II. Data: The managed access datasets to which the User Institution has requested access. Data Producers: Memorial Sloan Kettering Cancer Center and the collaborators listed in Appendix I responsible for the development, organization, and oversight of these Data. External Collaborator: A collaborator of the User, working for an institution other than the User Institution. Project: The project for which the User Institution has requested access to these Data. A description of the Project is set out in Appendix II. Publications: Includes, without limitation, articles published in print journals, electronic journals, reviews, books, posters and other written and verbal presentations of research. Research Participant: An individual whose data form part of these Data. Research Purposes: Shall mean research that is seeking to advance the understanding of genetics and genomics, including the treatment of disorders, and work on statistical methods that may be applied to such research. User: The principal investigator for the Project. User Institution(s): The Institution that has requested access to the Data. MSKCC: Memorial Sloan Kettering Cancer Center, 1275 York Avenue New York NY 10065. 1. The User Institution agrees to only use these Data for the purpose of the Project (described in Appendix II) and only for Research Purposes. The User Institution further agrees that it will only use these Data for Research Purposes which are within the limitations (if any) set out in Appendix I. 2. The User Institution agrees to preserve, at all times, the confidentiality of these Data. In particular, it undertakes not to use, or attempt to use these Data to compromise or otherwise infringe the confidentiality of information on Research Participants. Without prejudice to the generality of the foregoing, the User Institution agrees to use at least the measures set out in Appendix I to protect these Data. 3. The User Institution agrees to protect the confidentiality of Research Participants in any research papers or publications that they prepare by taking all reasonable care to limit the possibility of identification. 4. The User Institution agrees not to link or combine these Data to other information or archived data available in a way that could re-identify the Research Participants, even if access to that data has been formally granted to the User Institution or is freely available without restriction. 5. The User Institution agrees only to transfer or disclose these Data, in whole or part, or any material derived from these Data, to the Authorised Personnel. Should the User Institution wish to share these Data with an External Collaborator, the External Collaborator must complete a separate application for access to these Data. 6. The User Institution agrees that the Data Producers, and all other parties involved in the creation, funding or protection of these Data: a) make no warranty or representation, express or implied as to the accuracy, quality or comprehensiveness of these Data; b) exclude to the fullest extent permitted by law all liability for actions, claims, proceedings, demands, losses (including but not limited to loss of profit), costs, awards damages and payments made by the Recipient that may arise (whether directly or indirectly) in any way whatsoever from the Recipient’s use of these Data or from the unavailability of, or break in access to, these Data for whatever reason and; c) bear no responsibility for the further analysis or interpretation of these Data. 7. The User Institution agrees to follow the Fort Lauderdale Guidelines ( ) and the Toronto Statement ( This includes but is not limited to recognizing the contribution of the Data Producers and including a proper acknowledgement in all reports or publications resulting from the use of these Data. 8. The User Institution agrees to follow the Publication Policy in Appendix III. This includes respecting the moratorium period for the Data Producers to publish the first peer-reviewed report describing and analysing these Data. 9. The User Institution agrees not to make intellectual property claims on these Data and not to use intellectual property protection in ways that would prevent or block access to, or use of, any element of these Data, or conclusion drawn directly from these Data. 10. The User Institution can elect to perform further research that would add intellectual and resource capital to these data and decide to obtain intellectual property rights on these downstream discoveries. In this case, the User Institution agrees to implement licensing policies that will not obstruct further research and to follow the U.S. National Institutes of Health Best Practices for the Licensing of Genomic Inventions (2005) ( ) in conformity with the Organisation for Economic Co-operation and Development Guidelines for the Licensing of the Genetic Inventions (2006) ( ). 11. The User Institution agrees to destroy/discard the Data held, once it is no longer used for the Project, unless obliged to retain the data for archival purposes in conformity with audit or legal requirements. 12. The User Institution will notify MSKCC within 30 days of any changes or departures of Authorised Personnel. 13. The User Institution will notify MSKCC prior to any significant changes to the protocol for the Project. 14. The User Institution will notify MSKCC as soon as it becomes aware of a breach of the terms or conditions of this agreement. 15. MSKCC may terminate this agreement by written notice to the User Institution. If this agreement terminates for any reason, the User Institution will be required to destroy any Data held, including copies and backup copies. This clause does not prevent the User Institution from retaining these data for archival purpose in conformity with audit or legal requirements. 16. The User Institution accepts that it may be necessary for the Data Producers to alter the terms of this agreement from time to time. In the event that changes are required, the Data Producers or their appointed agent will contact the User Institution to inform it of the changes and the User Institution may elect to accept the changes or terminate the agreement. 17. If requested, the User Institution will allow data security and management documentation to be inspected to verify that it is complying with the terms of this agreement. 18. The User Institution agrees to distribute a copy of these terms to the Authorised Personnel. The User Institution will procure that the Authorised Personnel comply with the terms of this agreement. 19. This agreement (and any dispute, controversy, proceedings or claim of whatever nature arising out of this agreement or its formation) shall be construed, interpreted and governed by the laws of the United States and shall be subject to the exclusive jurisdiction of the United States courts.

Studies are experimental investigations of a particular phenomenon, e.g., case-control studies on a particular trait or cancer research projects reporting matching cancer normal genomes from patients.

Study ID Study Title Study Type
EGAS00001006377 Other
ID File Type Size Located in
EGAF00006223651 fastq.gz 2.1 GB
EGAF00006223652 fastq.gz 2.1 GB
EGAF00006223653 fastq.gz 1.1 GB
EGAF00006223654 fastq.gz 1.1 GB
EGAF00006223655 fastq.gz 1.7 GB
EGAF00006223656 fastq.gz 1.7 GB
EGAF00006223657 fastq.gz 1.9 GB
EGAF00006223658 fastq.gz 1.9 GB
EGAF00006223659 fastq.gz 1.9 GB
EGAF00006223660 fastq.gz 1.9 GB
EGAF00006223661 fastq.gz 1.6 GB
EGAF00006223662 fastq.gz 1.6 GB
EGAF00006223663 fastq.gz 1.9 GB
EGAF00006223664 fastq.gz 1.9 GB
EGAF00006223665 fastq.gz 1.6 GB
EGAF00006223666 fastq.gz 1.6 GB
EGAF00006223667 fastq.gz 1.1 GB
EGAF00006223668 fastq.gz 1.1 GB
EGAF00006223669 fastq.gz 2.3 GB
EGAF00006223670 fastq.gz 2.3 GB
EGAF00006223671 fastq.gz 2.2 GB
EGAF00006223672 fastq.gz 2.2 GB
EGAF00006223673 fastq.gz 1.7 GB
EGAF00006223674 fastq.gz 1.8 GB
EGAF00006223675 fastq.gz 2.4 GB
EGAF00006223676 fastq.gz 2.5 GB
EGAF00006223677 fastq.gz 1.9 GB
EGAF00006223678 fastq.gz 1.9 GB
EGAF00006223679 fastq.gz 2.1 GB
EGAF00006223680 fastq.gz 2.1 GB
EGAF00006223681 fastq.gz 1.7 GB
EGAF00006223682 fastq.gz 1.7 GB
EGAF00006223683 fastq.gz 1.3 GB
EGAF00006223684 fastq.gz 1.3 GB
EGAF00006223685 fastq.gz 1.5 GB
EGAF00006223686 fastq.gz 1.5 GB
EGAF00006223687 fastq.gz 917.0 MB
EGAF00006223688 fastq.gz 934.9 MB
EGAF00006223689 fastq.gz 1.2 GB
EGAF00006223690 fastq.gz 1.2 GB
EGAF00006223691 fastq.gz 1.4 GB
EGAF00006223692 fastq.gz 1.4 GB
EGAF00006223693 fastq.gz 2.0 GB
EGAF00006223694 fastq.gz 2.0 GB
EGAF00006223695 fastq.gz 835.4 MB
EGAF00006223696 fastq.gz 860.1 MB
EGAF00006223697 fastq.gz 788.3 MB
EGAF00006223698 fastq.gz 803.4 MB
EGAF00006223699 fastq.gz 1.0 GB
EGAF00006223700 fastq.gz 1.1 GB
EGAF00006223701 fastq.gz 1.1 GB
EGAF00006223702 fastq.gz 1.1 GB
EGAF00006223703 fastq.gz 1.4 GB
EGAF00006223704 fastq.gz 1.4 GB
EGAF00006223705 fastq.gz 1.4 GB
EGAF00006223706 fastq.gz 1.5 GB
EGAF00006223707 fastq.gz 1.3 GB
EGAF00006223708 fastq.gz 1.4 GB
EGAF00006223709 fastq.gz 1.9 GB
EGAF00006223710 fastq.gz 2.0 GB
EGAF00006223711 fastq.gz 1.2 GB
EGAF00006223712 fastq.gz 1.3 GB
EGAF00006223713 fastq.gz 1.6 GB
EGAF00006223714 fastq.gz 1.6 GB
EGAF00006223715 fastq.gz 1.3 GB
EGAF00006223716 fastq.gz 1.3 GB
EGAF00006223717 fastq.gz 1.2 GB
EGAF00006223718 fastq.gz 1.2 GB
EGAF00006223719 fastq.gz 299.2 MB
EGAF00006223720 fastq.gz 305.2 MB
EGAF00006223721 fastq.gz 1.4 GB
EGAF00006223722 fastq.gz 1.4 GB
EGAF00006223723 fastq.gz 372.2 MB
EGAF00006223724 fastq.gz 385.7 MB
74 Files (109.9 GB)